Using machine learning to uncover heterogeneity of beta blocker response in heart failure.

Tison, Geoffrey H · Cell Rep Med · 2022

meta_analysis · Level I

Where this comes from

Abstract

A recent study by Karwath et al.<sup>1</sup> in <i>The Lancet</i> applied machine learning-based cluster analysis to pooled data from nine double-blind, randomized controlled trials of beta blockers, identifying subgroups of efficacy in patients with sinus rhythm and atrial fibrillation.

Medical subject headings